Xavier Prieur

FGF21 Improves the Adipocyte Dysfunction Related to Seipin Deficiency.

Identification of the LIM protein FHL2 as a coactivator of beta-catenin.

The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response element.

Thyroid hormone regulates the hypotriglyceridemic gene APOA5.

Hepatocyte nuclear factor-4alpha regulates the human apolipoprotein AV gene: identification of a novel response element and involvement in the control by peroxisome proliferator-activated receptor-gamma coactivator-1alpha, AMP-activated protein kinase, and mitogen-activated protein kinase pathway.

The lipoprotein lipase inhibitor ANGPTL3 is negatively regulated by thyroid hormone.

The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase.

Leptin regulates peripheral lipid metabolism primarily through central effects on food intake.

Functional characterization of naturally occurring pathogenic mutations in the human leptin receptor.

Differential regulation of the human versus the mouse apolipoprotein AV gene by PPARalpha. Implications for the study of pharmaceutical modifiers of hypertriglyceridemia in mice.

Lipotoxicity in macrophages: evidence from diseases associated with the metabolic syndrome.

Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice.

n-3 PUFA prevent metabolic disturbances associated with obesity and improve endothelial function in golden Syrian hamsters fed with a high-fat diet.

Ablation of PGC1 beta prevents mTOR dependent endoplasmic reticulum stress response.

Transintestinal cholesterol excretion is an active metabolic process modulated by PCSK9 and statin involving ABCB1.

Function of seipin: new insights from Bscl2/seipin knockout mouse models.

Congenital lipodystrophies and dyslipidemias.

Hematopoietic IKBKE limits the chronicity of inflammasome priming and metaflammation.

PCSK9-deficiency does not alter blood pressure and sodium balance in mouse models of hypertension.

The SGLT2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model.